Breast/lungcancer
41 – 50 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Detection of Non-Small Lung Cell Carcinoma-Associated Genetic Alterations Using a NanoString Gene Expression Platform Approach
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
(
- Contribution to journal › Article
-
Mark
Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
(
- Contribution to journal › Article
-
Mark
An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
(
- Contribution to journal › Article
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
(
- Contribution to journal › Article
-
Mark
Random forest modelling of high-dimensional mixed-type data for breast cancer classification
(
- Contribution to journal › Article
- 2020
-
Mark
Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers
(
- Contribution to journal › Letter
-
Mark
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma
(
- Contribution to journal › Article